Homotype-Targeted Biogenic Nanoparticles to Kill Multidrug-Resistant Cancer Cells

“Off-targeting” and receptor density expressed at the target sites always compromise the efficacy of the nanoparticle-based drug delivery systems. In this study, we isolated different cell membranes and constructed cell membrane-cloaked biogenic nanoparticles for co-delivery of antitumor paclitaxel...

Descripción completa

Detalles Bibliográficos
Autores principales: Shair Mohammad, Imran, Chaurasiya, Birendra, Yang, Xuan, Lin, Chuchu, Rong, Hehui, He, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600481/
https://www.ncbi.nlm.nih.gov/pubmed/33050126
http://dx.doi.org/10.3390/pharmaceutics12100950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600481/
https://www.ncbi.nlm.nih.gov/pubmed/33050126
http://dx.doi.org/10.3390/pharmaceutics12100950

Ejemplares similares